BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 78 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,688,412 | -11.7% | 186,566 | +0.6% | 0.01% | 0.0% |
| Q2 2023 | $3,046,318 | +20.8% | 185,525 | +23.0% | 0.01% | 0.0% |
| Q1 2023 | $2,521,260 | +50.2% | 150,883 | +38.7% | 0.01% | +66.7% |
| Q4 2022 | $1,678,310 | +7.3% | 108,769 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $1,564,000 | +21.5% | 104,735 | +33.7% | 0.00% | 0.0% |
| Q2 2022 | $1,287,000 | -7.2% | 78,308 | +13.3% | 0.00% | 0.0% |
| Q1 2022 | $1,387,000 | -8.4% | 69,130 | +15.8% | 0.00% | 0.0% |
| Q4 2021 | $1,514,000 | -26.8% | 59,717 | -22.1% | 0.00% | -25.0% |
| Q3 2021 | $2,067,000 | +21.4% | 76,622 | +30.1% | 0.00% | +33.3% |
| Q2 2021 | $1,703,000 | +25.9% | 58,881 | +14.5% | 0.00% | 0.0% |
| Q1 2021 | $1,353,000 | +6.0% | 51,435 | +15.5% | 0.00% | 0.0% |
| Q4 2020 | $1,276,000 | +245.8% | 44,543 | +152.5% | 0.00% | +200.0% |
| Q2 2020 | $369,000 | +30.9% | 17,641 | +12.0% | 0.00% | 0.0% |
| Q1 2020 | $282,000 | – | 15,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logan Stone Capital, LLC | 177,757 | $2,921,000 | 2.15% |
| EPIQ PARTNERS, LLC | 165,694 | $2,722,000 | 1.67% |
| Matisse Capital | 82,000 | $1,347,000 | 1.28% |
| Cornerstone Advisors, LLC | 1,243,053 | $20,423,000 | 1.07% |
| Quantedge Capital Pte Ltd | 319,600 | $5,251,000 | 1.06% |
| 1607 Capital Partners, LLC | 836,082 | $13,737,000 | 0.94% |
| Nova R Wealth, Inc. | 31,622 | $520,000 | 0.43% |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | 337,938 | $5,542,000 | 0.40% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 178,520 | $2,933,000 | 0.40% |
| BlackDiamond Wealth Management, LLC | 14,917 | $256,000 | 0.32% |